Details

Title
Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy
Author
Frechette, Kelsey M. 1 ; Lester, Scott C. 1 ; Taparra, Kekoa 2   VIAFID ORCID Logo  ; Breen, William G. 1 ; Martenson, James A. 1 ; Hoppe, Bradford S. 3 ; Peterson, Jennifer L. 3 ; Rule, William G. 4 ; Stafford, Scott L. 1 ; Stish, Bradley J. 1 ; Habermann, Thomas M. 5 ; Young, Jason R. 6   VIAFID ORCID Logo  ; Harmsen, William S. 7 ; Laack, Nadia N. 1   VIAFID ORCID Logo 

 Mayo Clinic, Department of Radiation Oncology, Rochester, USA (GRID:grid.66875.3a) (ISNI:0000 0004 0459 167X) 
 Stanford Medicine, Department of Radiation Oncology, Palo Alto, USA (GRID:grid.240952.8) (ISNI:0000000087342732) 
 Mayo Clinic, Department of Radiation Oncology, Jacksonville, USA (GRID:grid.417467.7) (ISNI:0000 0004 0443 9942) 
 Mayo Clinic, Department of Radiation Oncology, Scottsdale, USA (GRID:grid.417468.8) (ISNI:0000 0000 8875 6339) 
 Mayo Clinic, Department of Hematology, Rochester, USA (GRID:grid.66875.3a) (ISNI:0000 0004 0459 167X) 
 Mayo Clinic, Department of Radiology, Rochester, USA (GRID:grid.66875.3a) (ISNI:0000 0004 0459 167X) 
 Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, USA (GRID:grid.66875.3a) (ISNI:0000 0004 0459 167X) 
Publication year
2022
Publication date
Aug 2022
Publisher
Springer Nature B.V.
e-ISSN
20445385
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2705219729
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.